Article 20 Jan 2020 U.S. Antitrust Agencies Issue First Vertical Merger Guidelines In 35 Years United States Anti-trust
Article 28 Sep 2017 Antitrust Bills Seek To Thwart Mega Mergers And Expand Antitrust Enforcement United States Anti-trust
Article 04 Sep 2017 "Better Deal" Legislative Proposal Would Overhaul U.S. Antitrust Merger Review United States Anti-trust
Article 18 Aug 2016 U.S. FTC Challenges Ambiguous "Invitation To Collude" In Supplier-Distributor Relationship United States Anti-trust
Article 20 Apr 2016 U.S. DOJ And FTC Promise Pentagon Aggressive Antitrust Enforcement In Defense Mergers United States Anti-trust
Article 20 Feb 2015 FDA Issued The Following Draft And Final Guidance Documents United States Healthcare
Article 20 Feb 2015 FDA Invites Comments On WHO Recommendations For Narcotics United States Healthcare
Article 19 Feb 2015 FDA-CDER Continues Site Tours Program, Invites Pharma To Participate United States Healthcare
Article 19 Feb 2015 FDA Modifies Recognized Consensus Standards For Medical Devices United States Healthcare
Article 19 Feb 2015 FDA Republishes PMA Order For Automated External Defibrillator United States Healthcare
Article 18 Feb 2015 FDA Authorizes Emergency Use Of IV Diagnostics For Ebola Detection United States Healthcare
Article 18 Feb 2015 European Agency Launches Central Repository To Facilitate Assessment Of Medicines Safety Reports European Union Healthcare
Article 17 Feb 2015 Mexican Health Ministry Establishes Requirements For Approving Biotech And Biosimilars Mexico Healthcare
Article 17 Feb 2015 European Court Of Justice Rules On Orphan Drug Market Exclusivity European Union Healthcare
Article 16 Feb 2015 House Committee Considers 21st Century Cures Draft, Senate Coordinates Sister Bill United States Healthcare
Article 16 Feb 2015 President's Proposed FY 2016 Budget Includes Increased Funding For FDA United States Healthcare
Article 16 Feb 2015 FDA Considers Approaches For Regulating Next-Generation DNA Sequencing United States Healthcare
Article 16 Feb 2015 FDA Revises Draft Guidance On Drug Promotional Materials United States Healthcare